title: The comparative pharmacokinetics and gastric toxicity of bezafibrate and ciprofibrate in the rat.
abstract: 1. The comparative gastric toxicology and pharmacokinetics of two phenoxyisobutyrate derivatives have been evaluated in the Fischer rat. 2. After oral administration of single daily doses for 7 days, the plasma elimination half-life for bezafibrate was rapid (t1/2 of 4-5 h) in comparison to ciprofibrate (t1/2 of 76 h). 3. The area under the plasma drug concentration versus time curve (AUC) 0-24 (micrograms.h/ml +/- SD) for bezafibrate (dose 125 mg/kg per day) was 1553 +/- 334, which was less than half the value of 3748 +/- 358 achieved by ciprofibrate (10 mg/kg per day) after 7 days. 4. Oral administration of ciprofibrate at 10 mg/kg every 48 h produced similar sustained plasma concentrations to those achieved by bezafibrate 125 mg/kg dosed every 12 h. The AUC 0-48 values (micrograms.h/ml +/- SD) achieved were 5124 +/- 450 for bezafibrate compared to 4207 +/- 240 for ciprofibrate. 5. In chronic oral multidose studies with ciprofibrate and bezafibrate, similar gastric toxicity (neuroendocrine cell hyperplasia) occurred in the rat when dose regimens were adjusted to compensate for the pharmacokinetic differences between these two drugs.
authors.affiliation: Department of Toxicology, Sterling-Winthrop Research Centre, Northumberland, U.K.
authors.forename: C T
authors.initials: CT
authors.lastname: Eason
authors.forename: P
authors.initials: P
authors.lastname: Powles
authors.forename: G
authors.initials: G
authors.lastname: Henry
authors.forename: A J
authors.initials: AJ
authors.lastname: Spencer
authors.forename: A
authors.initials: A
authors.lastname: Pattison
authors.forename: F W
authors.initials: FW
authors.lastname: Bonner
mesh_terms: D000284:Administration, Oral; D000818:Animals; D001629:Bezafibrate / Q000008:administration & dosage / Q000493:pharmacokinetics* / Q000633:toxicity; D002995:Clofibric Acid / Q000008:administration & dosage / Q000493:pharmacokinetics / Q000633:toxicity; D004305:Dose-Response Relationship, Drug; D058607:Fibric Acids; D005753:Gastric Mucosa / Q000187:drug effects; D005755:Gastrins / Q000097:blood; D000960:Hypolipidemic Agents / Q000008:administration & dosage / Q000493:pharmacokinetics* / Q000633:toxicity; D008297:Male; D009490:Neurosecretory Systems / Q000166:cytology / Q000187:drug effects; D051381:Rats; D011916:Rats, Inbred F344; D013276:Stomach Ulcer / Q000139:chemically induced*
chemical_list: D058607:Fibric Acids; D005755:Gastrins; D000960:Hypolipidemic Agents; D002995:Clofibric Acid; C019304:ciprofibrate; D001629:Bezafibrate